source
- Star raises $200 million after successful spinouts of Electra and Vega TherapeuticsStar, a biopharma company, announced it has secured $200 million in new funding. The capital follows the recent exits of its subsidiaries Electra Therapeutics and Vega Therapeutics, which were spu…
- Family reflects on extra months gained from new pancreatic cancer drug daraxonrasibBobby Senaha was among the first patients to receive daraxonrasib, a new medicine aimed at extending survival for people with pancreatic cancer. The drug is described as life extending, offering p…